AAAAAA
Results:
1-22
|
Results: 22
Authors:
Brown, NJ
Murphey, LJ
Srikuma, N
Koschachuhanan, N
Williams, GH
Vaughan, DE
Citation: Nj. Brown et al., Interactive effect of PAI-1 4G/5G genotype and salt intake on PAI-1 antigen, ART THROM V, 21(6), 2001, pp. 1071-1077
Authors:
Wilsdorf, T
Gainer, JV
Murphey, LJ
Vaughan, DE
Brown, NJ
Citation: T. Wilsdorf et al., Angiotensin-(1-7) does not affect vasodilator or TPA responses to bradykinin in human forearm, HYPERTENSIO, 37(4), 2001, pp. 1136-1140
Authors:
Gainer, JV
Stein, CM
Neal, T
Vaughan, DE
Brown, NJ
Citation: Jv. Gainer et al., Interactive effect of ethnicity and ACE insertion/deletion polymorphism onvascular reactivity, HYPERTENSIO, 37(1), 2001, pp. 46-51
Authors:
Kaikita, K
Fogo, AB
Ma, LJ
Schoenhard, JA
Brown, NJ
Vaughan, DE
Citation: K. Kaikita et al., Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition, CIRCULATION, 104(7), 2001, pp. 839-844
Authors:
Murphey, LJ
Hachey, DL
Vaughan, DE
Brown, NJ
Morrow, JD
Citation: Lj. Murphey et al., Quantification of BK1-5, the stable bradykinin plasma metabolite in humans, by a highly accurate liquid-chromatographic tandem mass spectrometric assay, ANALYT BIOC, 292(1), 2001, pp. 87-93
Authors:
Vaughan, DE
Citation: De. Vaughan, Angiotensin, fibrinolysis, and vascular homeostasis, AM J CARD, 87(8A), 2001, pp. 18C-24C
Authors:
Vaughan, DE
Citation: De. Vaughan, Plasminogen activator inhibitor-1 and vascular disease in diabetes mellitus, CONTEMP CAR, 2001, pp. 237-243
Authors:
Vaughan, DE
Jacobson, SH
Armstrong, DE
Citation: De. Vaughan et al., A new neighborhood function for discrete manufacturing process design optimization using generalized hill climbing algorithms, J MEC DESIG, 122(2), 2000, pp. 164-171
Authors:
Brown, NJ
Nakamura, S
Ma, LJ
Nakamura, I
Donnert, E
Freeman, M
Vaughan, DE
Fogo, AB
Citation: Nj. Brown et al., Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo, KIDNEY INT, 58(3), 2000, pp. 1219-1227
Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo
Authors:
Nakamura, S
Nakamura, I
Ma, LJ
Vaughan, DE
Fogo, AB
Citation: S. Nakamura et al., Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo, KIDNEY INT, 58(1), 2000, pp. 251-259
Authors:
Coats, SR
Covington, JW
Su, M
Pabon-Pena, LM
Eren, M
Hao, Q
Vaughan, DE
Citation: Sr. Coats et al., SSeCKS gene expression in vascular smooth muscle cells: Regulation by angiotensin II and a potential role in the regulation of PAI-1 gene expression, J MOL CEL C, 32(12), 2000, pp. 2207-2219
Authors:
Brown, NJ
Kim, KS
Chen, YQ
Blevins, LS
Nadeau, JH
Meranze, SG
Vaughan, DE
Citation: Nj. Brown et al., Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production, J CLIN END, 85(1), 2000, pp. 336-344
Authors:
Murphey, LJ
Gainer, JV
Vaughan, DE
Brown, NJ
Citation: Lj. Murphey et al., Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin, CIRCULATION, 102(8), 2000, pp. 829-832
Authors:
Vaughan, DE
Brown, NJ
Citation: De. Vaughan et Nj. Brown, Effects of acute angiotensin II type 1 receptor antagonism and angiotensinconverting enzyme inhibition on plasma fibrinolytic parameters in patientswith heart failure, CIRCULATION, 102(6), 2000, pp. E43-E43
Authors:
Brown, NJ
Gainer, JV
Murphey, LJ
Vaughan, DE
Citation: Nj. Brown et al., Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B-2 receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway, CIRCULATION, 102(18), 2000, pp. 2190-2196
Authors:
Vaughan, DE
Citation: De. Vaughan, AT(1) receptor blockade and atherosclerosis - Hopeful insights into vascular protection, CIRCULATION, 101(13), 2000, pp. 1496-1497
Authors:
Venkov, CD
Myers, PR
Tanner, MA
Su, M
Vaughan, DE
Citation: Cd. Venkov et al., Ethanol increases endothelial nitric oxide production through modulation of nitric oxide synthase expression, THROMB HAEM, 81(4), 1999, pp. 638-642
Authors:
Brown, NJ
Agirbasli, M
Vaughan, DE
Citation: Nj. Brown et al., Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans, HYPERTENSIO, 34(2), 1999, pp. 285-290
Authors:
Brown, NJ
Gainer, JV
Stein, CM
Vaughan, DE
Citation: Nj. Brown et al., Bradykinin stimulates tissue plasminogen activator release in human vasculature, HYPERTENSIO, 33(6), 1999, pp. 1431-1435
Authors:
Limbird, LE
Vaughan, DE
Citation: Le. Limbird et De. Vaughan, Augmenting beta receptors in the heart: Short-term gains offset by long-term pains?, P NAS US, 96(13), 1999, pp. 7125-7127
Authors:
Brown, NJ
Agirbasli, MA
Williams, GH
Litchfield, WR
Vaughan, DE
Citation: Nj. Brown et al., Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1, HYPERTENSIO, 32(6), 1998, pp. 965-971
Authors:
Roselli, HT
Su, M
Washington, K
Kerins, DM
Vaughan, DE
Russell, WE
Citation: Ht. Roselli et al., Liver regeneration is transiently impaired in urokinase-deficient mice, AM J P-GAST, 38(6), 1998, pp. G1472-G1479
Risultati:
1-22
|